Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Drug Safety|August 28, 2001
Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoringD Layton, G L Pearce, S A ShakirDrug Safety|March 10, 2001
Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reportingP Biswas, L V Wilton, S A ShakirOptics Letters|September 10, 2009
Saturation effects in the carrier-induced refractive index in a semiconductor gain mediumW W Chow, G C Dente, D DepatieOptics Letters|September 16, 2009
Analysis of grating-coupled surface-emitting lasersS A Shakir, T C Salvi, G C DenteJournal of Psychopharmacology (Oxford, England)|February 24, 2001
Adverse effects associated with the use of donepezil in general practice in EnglandN R Dunn, G L Pearce, S A ShakirAmerican Journal of Psychotherapy|April 1, 1981
Group therapy in the management of manic-depressive illnessF R Volkmar, S Bacon, S A Shakir, et al.European Journal of Clinical Pharmacology|September 11, 2001
Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997P M Craig-McFeely, N V Acharya, S A ShakirEuropean Journal of Clinical Pharmacology|June 22, 2001
Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in EnglandD Layton, D W Clark, G L Pearce, et al.Lancet (London, England)|December 14, 2001
Prescription-event monitoring and reporting of adverse drug reactionsE Heeley, J Riley, D Layton, et al.Journal of Psychopharmacology (Oxford, England)|July 13, 2001
Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapineL V Wilton, E L Heeley, R M Pickering, et al.Pageof 3